Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0001415889-25-023564 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-03 | 2025-09-01+ | KNSA | Megna Michael R | CAO | M - OptEx | $17.92 | +20.6K | 35.4K | +140% | +$369.6K |
| DM | 2025-09-03 | 2025-09-01+ | KNSA | Megna Michael R | CAO | F - Tax | $33.55 | -4,657 | 37.6K | -11% | -$156.3K |
| D | 2025-09-03 | 2025-09-03 | KNSA | Megna Michael R | CAO | S - Sale+OE | $34.84 | -11.0K | 38.0K | -22% | -$383.2K |
| DM | 2025-09-03 | 2025-09-01+ | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -20.6K | 0 | -100% | $0 |
| DM | 2025-09-03 | 2025-09-01 | KNSA | Megna Michael R | CAO | A - Grant | $0.00 | +31.7K | 10.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-09-01 | M | A | 3,933 | — | 41,894 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 2 | Common | Class A Ordinary Share | 2025-09-02 | M | A | 774 | — | 38,386 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 3 | Common | Class A Ordinary Share | 2025-09-02 | F | D | 375 | $34.28 | 38,011 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-09-03 | M | A | 11,000 | $17.92 | 49,011 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2025-09-03 | S | D | 11,000 | $34.84 | 38,011 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $34.80 and $35.005. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Common | Class A Ordinary Share | 2025-09-01 | M | A | 2,557 | — | 37,961 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 7 | Common | Class A Ordinary Share | 2025-09-01 | M | A | 2,363 | — | 35,404 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 8 | Common | Class A Ordinary Share | 2025-09-01 | F | D | 4,282 | $33.49 | 37,612 | D | — | — | |
| 9 | Derivative | Restricted Share Unit | 2025-09-01 | M | D | 2,557 | $0.00 | 5,115 | D | — · — to — | 2,557 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F7) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. |
| 10 | Derivative | Restricted Share Unit | 2025-09-01 | M | D | 3,933 | $0.00 | 3,932 | D | — · — to — | 3,933 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F8) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |
| 11 | Derivative | Share Option | 2025-09-03 | M | D | 11,000 | $0.00 | 0 | D | $17.92 · — to 2029-03-03 | 11,000 Class A Ordinary Share | (F10) The option is fully vested and Exercisable. |
| 12 | Derivative | Restricted Share Unit | 2025-09-01 | M | D | 2,363 | $0.00 | 7,087 | D | — · — to — | 2,363 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024. |
| 13 | Derivative | Share Option | 2025-09-01 | A | A | 21,150 | $0.00 | 21,150 | D | $33.49 · — to 2035-08-31 | 21,150 Class A Ordinary Share | (F5) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2025. |
| 14 | Derivative | Restricted Share Unit | 2025-09-01 | A | A | 10,575 | $0.00 | 10,575 | D | — · — to — | 10,575 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025. |
| 15 | Derivative | Restricted Share Unit | 2025-09-02 | M | D | 774 | $0.00 | 0 | D | — · — to — | 774 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F9) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. |